Overview
This study is to evaluate the efficacy and safety of DA-5219 in patients with acute or chronic gastritis
Eligibility
Main Inclusion Criteria:
- Men or women aged ≥ 19 years and ≤ 75 years
- Subjects who diagnosed with acute or chronic gastritis by upper gastrointestinal endoscopy within 7days prior to the randomization
- Subjects who have one or more erosions identified on upper gastrointestinal endoscopy within 7days prior to the randomization
- Subjects who voluntarily signed a consent form
Main Exclusion Criteria:
- Ineligible for upper gastrointestinal endoscopy
- Subjects with active or healing gastroduodenal ulcer, reflux esophagitis, Barrett's esophagus, or gastroesophageal varices identified on upper gastrointestinal endoscopy within 7days prior to the randomization
- Subjects with hypersensitivity to investigational drugs and similar drugs
- Pregnant or breastfeeding women